Veracyte
VCYT
74 hedge funds and large institutions have $160M invested in Veracyte in 2016 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 32 increasing their positions, 11 reducing their positions, and 3 closing their positions.
633% more first-time investments, than exits
New positions opened: 22 | Existing positions closed: 3
191% more repeat investments, than reductions
Existing positions increased: 32 | Existing positions reduced: 11
174% more call options, than puts
Call options by funds: $2.9M | Put options by funds: $1.06M
62.83% more ownership
Funds ownership: 0% → 62.83% (+63%)
35% more capital invested
Capital invested by funds: $118M → $160M (+$41.4M)
35% more funds holding
Funds holding: 55 → 74 (+19)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Top Buyers
| 1 |
BC
Broadfin Capital
New York
|
+$13.4M |
| 2 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
+$7.26M |
| 3 |
CC
Cannell Capital
Alta,
Wyoming
|
+$5.23M |
| 4 |
ACP
Acuta Capital Partners
Redwood City,
California
|
+$2.76M |
| 5 |
AI
Axiom Investors
Greenwich,
Connecticut
|
+$2.15M |
Top Sellers
| 1 |
GE
General Electric
Evendale,
Ohio
|
-$2.01M |
| 2 |
GTC
Ghost Tree Capital
New York
|
-$1.23M |
| 3 |
CCM
Consonance Capital Management
New York
|
-$891K |
| 4 |
WSA
Wall Street Associates
Lajolla,
California
|
-$813K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$307K |
VCYT Hedge Fund Activity: Q4 2016 in Review
74 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Veracyte (VCYT) for Q4 2016, worth a combined $160M — up 35% from $118M a quarter earlier.
Buyers outnumbered sellers: 22 funds opened new VCYT positions and 3 closed out — a net gain of 19 holders — while 32 added to existing stakes and 11 trimmed.
The largest buyer was Broadfin Capital, opening a new position worth an estimated $13.4M. The largest seller was General Electric, exiting entirely with an estimated $2.01M sold.
- 74 institutional investors held Veracyte (VCYT) as of Q4 2016, up from 55 in Q3 2016.
- Funds reported $160M of Veracyte stock for Q4 2016, up 35% quarter-over-quarter.
- 22 funds opened new Veracyte positions in Q4 2016 and 3 closed out, a net change of +19 holders.
- The largest Veracyte buyer in Q4 2016 was Broadfin Capital, an estimated $13.4M added.
- The largest Veracyte seller in Q4 2016 was General Electric, an estimated $2.01M sold.
Based on aggregated 13F filings for Q4 2016.